Menu
Not yet recruiting NCT07033559

Detecting Fatigue From Voice in Generalised Myasthenia Gravis

Observational Myasthenia Gravis Generalised

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Myasthenia Gravis Generalised. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Remote Digital Voice Biomarkers for Central Fatigue Detection in Generalised Myasthenia Gravis: An Online Single-Cohort Observational Study

Overview

The goal of this observational study is to learn if computer analysis of voice recordings can detect a type of exhaustion called "central fatigue" in adults with generalised myasthenia gravis. The main questions it aims to answer are: 1. Can advanced voice analysis accurately tell when participants are experiencing deep exhaustion based on how they speak? 2. How easy and acceptable is voice-based fatigue monitoring for people with myasthenia gravis? Participants will: 1. Record themselves reading short passages and answering questions out loud twice daily (morning and evening), twice a week, for 4 weeks. 2. Answer brief questionnaires about their energy levels, mood, and myasthenia gravis symptoms during each session. 3. Use their own devices (computer, tablet, or smartphone) to complete all study activities online from home.

Detailed description

This study addresses a significant gap in understanding and measuring central fatigue in generalised myasthenia gravis (gMG), a debilitating symptom that differs from the characteristic muscle weakness fluctuations of the condition. Central fatigue encompasses mental and physical exhaustion originating in the central nervous system and remains poorly characterised with limited validated assessment tools.

Study Rationale and Innovation:

Recent developments in artificial intelligence and digital biomarkers have demonstrated potential for detecting fatigue-related changes in voice characteristics. This approach offers advantages over traditional assessment methods by providing objective, standardised measurements that can be collected remotely with minimal participant burden. Voice-based biomarkers may capture subtle physiological changes associated with central fatigue that are not readily apparent through conventional questionnaire-based assessments.

Study Design and Methodology:

This single-cohort observational study employs an intensive longitudinal monitoring design to capture the dynamic nature of fatigue fluctuations characteristic of gMG. The twice-daily assessment schedule (morning and evening sessions two days a week) over four weeks is designed to account for diurnal variation in fatigue symptoms commonly reported by MG patients.

Each assessment session lasts approximately 10-15 minutes and includes standardised voice recording tasks alongside validated fatigue questionnaires. Voice recording activities consist of structured reading tasks and answering questions out loud, designed to elicit natural speech patterns while maintaining consistency across sessions and participants.

Technical Approach:

Voice data will be analysed using machine learning algorithms to identify acoustic features potentially associated with central fatigue states. \[Note: Specific algorithmic approaches and feature extraction methods are proprietary and not detailed here\]. The study uses triangulated participant self-reported fatigue assessments as ground truth labels for model training and validation.

Data Collection and Management:

All data collection occurs remotely through a secure web-based platform accessible via standard internet browsers. Participants use their personal devices (computers, tablets, or smartphones) equipped with microphone capabilities. The platform captures voice recordings, questionnaire responses, and relevant metadata including device specifications and environmental conditions that may affect recording quality.

Sample Size Considerations:

The target enrolment of 240 participants is designed to generate sufficient data points for robust machine learning model development while accounting for expected attrition and technical issues.

Primary outcome measures

  • Accuracy of AI Model for Binary Central Fatigue Classification as Assessed by Voice Biomarker Analysis [Time frame: Across 16 assessment sessions over 4 weeks from enrolment]
Secondary outcome measures (5)
  • Study Completion Rate Among Enrolled Participants [Time frame: From enrolment through completion of final assessment session at 4 weeks]
  • Individual Session Completion Rate Across All Participants [Time frame: From enrolment through completion of final assessment session at 4 weeks]
  • Adherence to Specified Assessment Time Windows [Time frame: From enrolment through completion of final assessment session at 4 weeks]
  • Participant Acceptability of Voice-Based Monitoring System [Time frame: At completion of final assessment session at 4 weeks]
  • Participant Withdrawal Patterns and Reasons [Time frame: From enrolment through 4 weeks or until participant withdrawal]

Eligibility criteria

Inclusion criteria

  • Adults ≥18 years old
  • Self-reported generalised Myasthenia Gravis diagnosis confirmed by healthcare provider for ≥6 months
  • Disease stability for ≥6 months (no hospitalisations, medication changes, or significant symptom worsening)
  • English as first language
  • Residence in US or UK
  • Vision adequate for screen reading (with aid or correction if necessary)
  • Access to internet-connected device with compatible browser and microphone
  • Adequate internet connectivity (≥5 Mbps download, ≥3 Mbps upload)
  • Ability to complete twice-daily assessments during specified time windows
  • Signed electronic informed consent

Exclusion criteria

  • Pure ocular Myasthenia Gravis
  • Diagnosed mild cognitive impairment or dyslexia
  • Speech or hearing impairments affecting voice recording
  • Unable to provide credible diagnostic information (healthcare provider diagnosis, antibody test results, current medications)
  • Major inconsistencies in reported medical history
  • Unsigned informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Publications

  • Regnault A, Habib AA, Creel K, Kaminski HJ, Morel T. Clinical meaningfulness and psychometric robustness of the MG Symptoms PRO scales in clinical trials in adults with myasthenia gravis. Front Neurol. 2024 Jun 24;15:1368525. doi: 10.3389/fneur.2024.1368525. eCollection 2024. PMID 38978809
  • Fara, S., Goria, S., Molimpakis, E., Cummins, N. (2022). Speech and the n-Back task as a lens into depression. How combining both may allow us to isolate different core symptoms of depression. Proc. INTERSPEECH 2022, 1911-1915.

Identifiers

NCT: NCT07033559 · RWE1049

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗